Jinghua Pharmaceutical Group Co., Ltd.

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100000L14
CNY
8.11
0.08 (1.0%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Mar'24
Dec'23
Net Sales
361.84
357.84
351.56
319.82
348.05
361.83
386.60
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
361.84
357.84
351.56
319.82
348.05
361.83
386.60
Raw Material Cost
168.96
179.91
186.26
174.58
178.38
185.91
206.20
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.23
0.23
0.00
0.61
0.73
0.73
0.64
Selling and Distribution Expenses
93.64
89.35
94.28
93.80
84.94
81.67
94.22
Other Expenses
1.72
0.94
1.37
1.31
1.36
1.53
1.80
Total Expenditure (Excl Depreciation)
280.06
278.86
294.22
282.06
277.62
283.59
319.02
Operating Profit (PBDIT) excl Other Income
81.8
79
57.300000000000004
37.8
70.4
78.2
67.6
Other Income
9.73
7.75
24.89
5.63
18.09
15.09
9.21
Operating Profit (PBDIT)
108.55
100.31
84.39
60.11
104.24
110.89
91.04
Interest
0.23
0.23
0.00
0.61
0.73
0.73
0.64
Exceptional Items
0.67
0.78
0.16
0.25
0.54
2.87
1.73
Gross Profit (PBDT)
192.87
177.94
165.30
145.24
169.67
175.92
180.40
Depreciation
17.36
17.36
16.44
16.44
17.26
17.26
18.79
Profit Before Tax
91.63
83.51
68.11
43.31
86.79
95.77
73.33
Tax
11.46
11.99
11.15
7.08
13.74
13.88
16.36
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
68.42
62.22
48.42
28.80
64.35
71.08
52.35
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
68.42
62.22
48.42
28.80
64.35
71.08
52.35
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
11.74
9.30
8.54
6.80
8.57
10.90
3.99
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
80.17
71.52
56.96
35.60
72.92
81.98
56.34
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
2,654.86
2,647.31
2,583.50
2,535.75
2,506.64
2,516.64
2,444.59
Earnings per share (EPS)
0.08
0.08
0.06
0.04
0.08
0.09
0.06
Diluted Earnings per share
0.08
0.08
0.06
0.04
0.08
0.09
0.06
Operating Profit Margin (Excl OI)
22.51%
21.02%
12.25%
11.9%
19.79%
21.71%
16.31%
Gross Profit Margin
30.12%
28.19%
24.05%
18.68%
29.89%
31.24%
23.83%
PAT Margin
18.91%
17.39%
13.77%
9.01%
18.49%
19.64%
13.54%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Jun 2025 is 1.12% vs 1.76% in Mar 2025

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Jun 2025 is 12.17% vs 25.44% in Mar 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Jun 2025 is 6.70% vs 55.63% in Mar 2025

stock-summary

Interest

QoQ Growth in quarter ended Jun 2025 is 0.00% vs 0.00% in Mar 2025

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Jun 2025 has improved from Mar 2025

Compare Quarterly Results Of Jinghua Pharmaceutical Group Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
361.84
0
361.84
Other Operating Income
0.00
0.00
0.00
Total Operating income
361.84
0
361.84
Raw Material Cost
168.96
0
168.96
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
0.23
0
0.23
Selling and Distribution Expenses
93.64
0
93.64
Other Expenses
1.72
0.00
1.72
Total Expenditure (Excl Depreciation)
280.06
0
280.06
Operating Profit (PBDIT) excl Other Income
81.78
0.00
81.78
Other Income
9.73
0
9.73
Operating Profit (PBDIT)
108.55
0
108.55
Interest
0.23
0
0.23
Exceptional Items
0.67
0
0.67
Gross Profit (PBDT)
192.87
0
192.87
Depreciation
17.36
0
17.36
Profit Before Tax
91.63
0
91.63
Tax
11.46
0
11.46
Provisions and contingencies
0
0
0.00
Profit After Tax
68.42
0
68.42
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
68.42
0
68.42
Share in Profit of Associates
0
0
0.00
Minority Interest
11.74
0
11.74
Other related items
0.00
0.00
0.00
Consolidated Net Profit
80.17
0
80.17
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
2,654.86
0
2,654.86
Earnings per share (EPS)
0.08
0
0.08
Diluted Earnings per share
0.08
0
0.08
Operating Profit Margin (Excl OI)
22.51%
0%
0.00
22.51%
Gross Profit Margin
30.12%
0%
0.00
30.12%
PAT Margin
18.91%
0%
0.00
18.91%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 36.18 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 1.12% vs 1.76% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 3.94% vs -6.88% in Jun 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 8.02 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 12.17% vs 25.44% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 10.01% vs -2.15% in Jun 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 9.88 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 6.70% vs 55.63% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 14.75% vs -4.55% in Jun 2024

Quarterly - Interest
Interest 0.02 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 0.00% vs 0.00% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is -71.43% vs 40.00% in Jun 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 22.51%
in Jun 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Jun 2025 has improved from Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 has improved from Jun 2024